Development and evaluation of chitosan-based nanoparticles for enhanced bioavailability of paclitaxe

来源 :2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年 | 被引量 : 0次 | 上传用户:dashaomai
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Polymeric nanoparticles have been increasingly investigated as promising nanocarriers for oral drug delivery.Based on the excellent characteristics of chitosan,two amphipathic copolymers polylysine-chitosan-polylactide(PL-CS-PLA)and polylysine-cysteine-chitosan-polylactide(PY-CS-PLA)were designed and synthesized for oral delivery of paclitaxel(PTX)to improve its oral bioavailability by increasing its water solubility and bypassing the P-gp drug efflux pumps.
其他文献
会议
Objective: This work aimed to develop an alternative sustained-release thermosensitive praziquantel-loaded nanoemulsion(PZQ-NE)hydrogel to better satisfy chronic schistosomiasis treatment.
会议
Objective: To improve the bioavailability of resveratrol,a poorly water soluble polyphenolic compound,via a novel formulation of microparticles and oral fast dissolving films(OFDFs).
会议
会议
Reduction-sensitive chondroitin sulfate A(CSA)-based micelles were developed.CSA was conjugated with deoxycholic acid(DOCA)via a disulfide linkage.
会议
会议
Solid lipid nanoparticles loaded with salmon calcitonin-phospholipid complex(sCT-SPC-SLN)were prepared by a film-dispersion method.
As potential drug delivery systems(DDSs),nanoparticles can enhance the efficacy of tumor treatment via EPR effect.However,few of them have been translated to clinic application due to the potential th
会议